Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.60
0.00 (0.00%)
At close: Aug 15, 2025, 11:13 AM
Brainstorm Cell Therapeutics Revenue
Brainstorm Cell Therapeutics reported an annual revenue of $849K, reflecting a 0% growth. For the quarter ending March 31, 2025, Brainstorm Cell Therapeutics generated $0 in revenue.
Revenue (ttm)
849K
Revenue Growth
n/a
Price / Sales Ratio
14.2
Revenue / Employee
31.44K
Employees
27
Market Cap
5.9M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|